Correction to: Psychopharmacology
10.1007/s00213-018-4977-6
The original version of this article contained a mistake in Table 5. Correct version is presented here.
Table 5.
Changes in clinical laboratory evaluations
| Baseline | End of treatment | Change from baseline | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Placebo group | Quetiapine XR 300 mg group | Quetiapine XR 150 mg group | Placebo group | Quetiapine XR 300 mg group | Quetiapine XR 150 mg group | Placebo group | Quetiapine XR 300 mg group | Quetiapine XR 150 mg group | ||||||||||
| Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | SD | |
| Body weight (kg) | 62.65 | 13.10 | 63.15 | 13.71 | 64.09 | 13.06 | 62.32 | 13.37 | 64.16 | 13.92 | 64.33 | 12.87 | -0.54 | 1.96 | 0.92 | 2.35 | 0.45 | 2.27 |
| Blood glucose (mg/dL) | 97.9 | 15.8 | 985 | 14.2 | 96.8 | 13.9 | 98.4 | 16.3 | 101.3 | 17.1 | 97.1 | 12.3 | 0.5 | 19.2 | 3.1 | 18.1 | 0.3 | 15.8 |
| HbA 1c (%) | 5.01 | 0.28 | 5.05 | 0.27 | 5.07 | 0.28 | 5.03 | 0.29 | 5.06 | 0.31 | 5.06 | 0.32 | 0.01 | 0.15 | 0.01 | 0.17 | -0.01 | 0.24 |
| Total cholesterol (mg/dL) | 195.1 | 39.9 | 191.0 | 35.6 | 192.7 | 40.8 | 191.2 | 33.4 | 195.5 | 37.5 | 193.8 | 36.1 | -4.1 | 23.3 | 4.9 | 26.0 | 1.1 | 28.2 |
| HDL-C (mg/dL) | 58.1 | 14.4 | 56.5 | 16.7 | 55.3 | 13.1 | 57.8 | 14.1 | 55.7 | 16.3 | 54.4 | 13.5 | -0.2 | 8.2 | -0.7 | 8.0 | -0.9 | 9.0 |
| LDL-C (mg/dL) | 117.2 | 3 7.4 | 115.4 | 32.0 | 116.9 | 36.3 | 115.3 | 31.3 | 118.4 | 32.3 | 119.1 | 31.2 | -2.3 | 21.5 | 3.2 | 18.7 | 2.2 | 22.8 |
| Triglycerides (mg/dL) | 136.4 | 109.8 | 128.2 | 80.1 | 126.8 | 92.8 | 121.6 | 86.2 | 147.0 | 112.4 | 139.3 | 106.6 | -15.1 | 87.8 | 18.9 | 91.3 | 12.5 | 62.5 |
| Prolactin (ng/mL) | 11.983 | 15.409 | 10.529 | 6.779 | 9.044 | 4.491 | 12.433 | 20.655 | 12.375 | 19.305 | 10.300 | 5.286 | 0.375 | 23.310 | 1.877 | 19.479 | 1.256 | 4.504 |
HbA1c, hemoglobin Alc; HDL-C, high-density lipoprotein-cholesterol; LDL-C, low-density lipoprotein-cholesterol
Footnotes
The online version of the original article can be found at 10.1007/s00213-018-4977-6
Contributor Information
Mitsukuni Murasaki, Email: murasaki@i-cnsp.com.
Tsukasa Koyama, Email: koyama@ohyachi-hp.or.jp.
Shigenobu Kanba, Email: skanba@npsych.med.kyushu-u.ac.jp.
Masahiro Takeuchi, Email: takeuchim@pharm.kitasato-u.ac.jp.
Yuriko Shimizu, Email: yuriko.shimizu@astellas.com.
Eri Arita, Email: eri.arita@astellas.com.
Kentaro Kuroishi, Email: kentarou.kuroishi@astellas.com.
Masahiro Takeuchi, Email: masahiro-takeuchi@astellas.com.
Shinya Kamei, Email: shinya.kamei@astellas.com.